| Income Statement |
| Total Revenue | 173.66B |
|
| Revenues (USD) | 5.43B |
| Cost of Revenue | 138.81B |
| Gross Profit | 34.85B |
| Operating Expenses | 17.32B |
| Research and Development Expense | 9.21B |
| Selling, General and Administrative Expense | 8.11B |
| Operating Income | 17.53B |
| Interest Expense | 1.58B |
| Income Tax Expense | 3.64B |
| Net Income | 14.15B |
| Net Income Common Stock | 14.15B |
| Net Income Common Stock (USD) | 441.99M |
| Consolidated Income | 14.15B |
| Earnings per Basic Share | 16.20 |
| Earnings per Basic Share (USD) | 0.51 |
| Earnings per Diluted Share | 15.40 |
| Earning Before Interest & Taxes (EBIT) | 19.36B |
| Earning Before Interest & Taxes (USD) | 604.78M |
| Weighted Average Shares | 4.49B |
| Weighted Average Shares Diluted | 4.49B |
| Balance Sheet |
| Cash and Equivalents | 87.81B |
| Cash and Equivalents (USD) | 2.74B |
| Investments | 76.74B |
| Investments Current | 26.14B |
| Investments Non-Current | 50.60B |
| Trade and Non-Trade Receivables | 126.01B |
| Current Assets | 337.70B |
| Property, Plant & Equipment Net | 471.74B |
| Total Assets | 957.53B |
| Debt Current | 55.82B |
| Total Debt | 256.96B |
| Current Liabilities | 294.50B |
| Debt Non-Current | 201.14B |
| Total Liabilities | 576.38B |
| Shareholders Equity | 350.62B |
| Shareholders Equity (USD) | 10.95B |
| Assets Non-Current | 619.83B |
| Total Debt (USD) | 8.03B |
| Goodwill and Intangible Assets | 65.04B |
| Inventory | 76.04B |
| Liabilities Non-Current | 281.88B |
| Trade and Non-Trade Payables | 86.90B |
| Cash Flow |
| Depreciation, Amortization & Accretion | 18.65B |
| Net Cash Flow from Financing | 838.00M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.66B |
| Capital Expenditure | -44.09B |
| Issuance (Repayment) of Debt Securities | 73.00M |
| Net Cash Flow from Investing | -45.74B |
| Net Cash Flow from Operations | 36.39B |
| Effect of Exchange Rate Changes on Cash | 3.86B |